Growth funding Strategic investments from IHH Healthcare and partnerships with academic and startup programs indicate growing validation and potential regard from large healthcare networks, presenting sales opportunities for integrated radiation therapy solutions and collaborative care platforms.

Clinical upgrade Leo Cancer Care partnership to upgrade Grace photon therapy with high-dose-rate, compact linac technology suggests a pathway for cross-sell opportunities with existing radiotherapy platforms seeking modernization and efficiency gains.

New platform Introduction of Galactica upright linac with emphasis on patient comfort and targeted treatment signals a product-driven expansion strategy that can create joint development or licensing talks with hospital systems prioritizing patient experience and throughput.

Academic ties Collaborations through Lehigh University Startup Academy and Stanford-origin technology provide credibility and access to research centers and grant-funded projects, enabling pilot programs and trial partnerships with academic medical centers.

Global reach Global press coverage and awards, coupled with a multi-region revenue profile (staffing scale and international investments), present opportunities to engage regional distributors, systems integrators, and international cancer centers seeking advanced radiotherapy capabilities.